GLP-1 Injection Site Rotation: Check the Instructions for Your Exact Product
August 12, 2026
Injectable GLP-1 medicines do not all use one interchangeable set of device instructions. If you use a prescription injectable product, the source for where and how to inject it is the current Instructions for Use and prescribing information for that exact product and device, together with your healthcare professional’s instructions.
A tracker can record the site you used. It should not invent a rotation schedule, choose the next site or teach injection technique.
What current product instructions have in common — and why the exact label still matters
Current U.S. FDA-approved instructions for products such as Wegovy (semaglutide) and Zepbound (tirzepatide) describe subcutaneous injection areas that include the abdomen and thigh and also address use of the upper arm. They also instruct users to vary the injection site rather than repeatedly using the same exact spot.
But details differ by product and presentation. For example, current Zepbound instructions specify that another person should administer an upper-arm injection, while the current Wegovy Instructions for Use provide their own product-specific site and device directions.
That is enough reason not to turn a multi-product article into a universal step-by-step injection guide.
Use the label that came with the medicine
Before using an injectable prescription medicine, check the current product Instructions for Use and the instructions supplied by the prescriber or pharmacy. If the device, concentration, presentation or product changes, read the instructions again rather than assuming the old technique carries over.
If anything about the injection site, device operation or technique is unclear, ask the prescribing or dispensing team to show you what applies to the exact medicine you have.
What a personal site log can record
A neutral record can include:
- date;
- medication and presentation as written on the label;
- dose as prescribed and actually recorded, without calculating one;
- injection site you used;
- any local reaction or symptom you want to remember;
- note about where the current official instructions are kept.
That history can help you remember what you did. It does not decide where the next injection should go.
Do not use a homemade six-week rotation as a prescription
A left-abdomen → right-abdomen → left-thigh → right-thigh → left-arm → right-arm sequence may look tidy in a spreadsheet, but it is not a universal FDA dosing schedule and should not be presented as one.
The product instructions may allow use of the same general body area while changing the exact injection site, and individual instructions can differ. Follow the exact product’s label and the healthcare professional who taught you how to use it.
Side-effect percentages do not belong in a site-rotation shortcut
Adverse-event rates vary by medicine, dose, indication, trial population and study design. A site-record article does not need to compare percentages across semaglutide, tirzepatide, clinical trials and online communities to tell someone whether their own symptoms are expected.
If you have side effects or a local injection-site reaction that concerns you, use the medication’s official patient information and contact the appropriate healthcare professional. Seek urgent or emergency care for symptoms that require it rather than using a tracker to interpret severity.
How the GentleTools tracker handles sites
The free GLP-1 Dose & Weight Record is designed to keep the site you entered last time visible alongside medication, dose, weight and symptoms you choose to log. It does not choose a next site, determine when another dose is due, verify injection technique or decide whether a reaction is safe.
For a broader medication-reference chart, use the Medication Schedule Builder, which also depends on instructions you already have rather than generating treatment instructions.
Sources and method. Product-specific examples were checked against current U.S. FDA-approved Instructions for Use for Wegovy and Zepbound. Product labeling can change and other GLP-1 medicines or device presentations may use different instructions. Always use the current instructions for the exact prescription product in hand.